CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Stemline Therapeutics Inc  (STML)
Other Ticker:  
 
 

STML's Net Income Growth by Quarter and Year

Stemline Therapeutics Inc's Net Income results by quarter and year




STML Net Income (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - -16.06 -9.92 -9.23
III Quarter September -21.04 -15.46 -9.32 -10.15
II Quarter June -18.42 -14.57 -9.05 -7.68
I Quarter March -21.75 -10.01 -10.18 -6.93
FY   -61.21 -56.10 -38.47 -33.99



STML Net Income third quarter 2018 Y/Y Growth Comment
Stemline Therapeutics Inc in the third quarter recorded net loss of $ -21.04 millions.

According to the results reported in the third quarter, Stemline Therapeutics Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Stemline Therapeutics Inc' s Net Income no change of % ranks overall at the positon no. in the third quarter.




STML Net Income ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Stemline Therapeutics Inc's third quarter 2018 Net Income $ 0.00 millions STML's Income Statement
Stemline Therapeutics Inc's third quarter 2017 Net Income $ 0.00 millions Quarterly STML's Income Statement
New: More STML's historic Net Income Growth >>


STML Net Income (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Stemline Therapeutics Inc's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


STML's III. Quarter Q/Q Net Income Comment
Current accomplishment of -21.04 millions by Stemline Therapeutics Inc come out even worse if you take a look at net loss -18.42 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Stemline Therapeutics Inc achieved highest sequential Net Income growth. While Stemline Therapeutics Inc's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


STML's III. Quarter Q/Q Net Income Comment
Current results of -21.04 millions by Stemline Therapeutics Inc come out even less good if you take a look at net loss -18.42 millions a quarter before.

Within Major Pharmaceutical Preparations industry Stemline Therapeutics Inc achieved highest sequential Net Income growth. While Stemline Therapeutics Inc's Net Income growth quarter on quarter, overall rank is .


Stemline Therapeutics Inc's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
12 Months Ending
(Jun 30 2017)
Cumulative Net Income 12 Months Ending $ -77.27 $ -71.68 $ -67.83 $ -56.09 $ -49.96
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Stemline Therapeutics Inc' has realized cumulative trailing twelve months net loss of $ -77 millions in the Sep 30 2018 period.
The results are getting worse as the cumulative net loss is inflating from $ -71.68 millions for the period from Mar 31 2018 to Jun 30 2017 and $ -18.42 millions from the TTM period ending Jun 30 2017 Carson B. Parker told.

Stemline Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Stemline Therapeutics Inc' has realized cumulative trailing twelve months net loss of $ -77 millions in the Sep 30 2018 period.
The business is worsening as the cumulative net loss is inflating from $ -71.68 millions in TTM ending quarter Mar 31 2018 and $ -18.42 millions from the TTM period ending Jun 30 2017.

Stemline Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


You need to upgrade your Flash Player




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
STML's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for STML's Competitors
Net Income Growth for Stemline Therapeutics Inc's Suppliers
Net Income Growth for STML's Customers

You may also want to know
STML's Annual Growth Rates STML's Profitability Ratios STML's Asset Turnover Ratio STML's Dividend Growth
STML's Roe STML's Valuation Ratios STML's Financial Strength Ratios STML's Dividend Payout Ratio
STML's Roa STML's Inventory Turnover Ratio STML's Growth Rates STML's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2018 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2018
Icu Medical Inc  61.03 %$ 61.029 millions
Dynatronics Corp  58.88 %$ 58.875 millions
Exelixis, Inc.  55.60 %$ 55.600 millions
Cambrex Corp  54.54 %$ 54.539 millions
Regeneron Pharmaceuticals Inc  53.14 %$ 53.136 millions
Boston Scientific Corporation  52.65 %$ 52.650 millions
Radnet, Inc.  49.99 %$ 49.987 millions
Masimo Corp  45.60 %$ 45.600 millions
Repro Med Systems Inc  45.46 %$ 45.455 millions
Chemed Corp  44.62 %$ 44.620 millions
Orasure Technologies Inc  40.48 %$ 40.482 millions
Stryker Corp  35.94 %$ 35.945 millions
Tabula Rasa Healthcare, Inc.  35.36 %$ 35.361 millions
Edwards Lifesciences Corp  32.80 %$ 32.804 millions
Idexx Laboratories Inc  32.19 %$ 32.192 millions
Tactile Systems Technology Inc  30.10 %$ 30.104 millions
Pacific Health Care Organization Inc  29.99 %$ 29.987 millions
Quest Diagnostics Inc  29.71 %$ 29.714 millions
Corcept Therapeutics Inc  29.00 %$ 29.003 millions
Encompass Health Corp  28.44 %$ 28.437 millions
Electromed, Inc.  27.47 %$ 27.470 millions
Merrimack Pharmaceuticals Inc  27.32 %$ 27.322 millions
Alpha Pro Tech Ltd  26.87 %$ 26.873 millions
Staar Surgical Co  24.38 %$ 24.382 millions
Tenax Therapeutics, Inc.  24.03 %$ 24.033 millions
Pdl Biopharma, Inc.  23.27 %$ 23.268 millions
Resmed Inc  22.77 %$ 22.772 millions
Petmed Express Inc  22.74 %$ 22.740 millions
Align Technology Inc  22.19 %$ 22.188 millions
Mettler Toledo International Inc  20.68 %$ 20.679 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GRMD's Profile

Stock Price

GRMD's Financials

Business Description

Fundamentals

Charts & Quotes

GRMD's News

Suppliers

GRMD's Competitors

Customers & Markets

Economic Indicators

GRMD's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071